What IJR’s Own History Says About Its Price Today
This popular small-cap fund is trading at a premium to its own history, forcing a hard look at whether the growth inside is enough to justify the price.
The companies inside the iShares Core S&P Small-Cap ETF (IJR) are expected to grow their collective earnings by about 15% over the next year. That’s a healthy clip. The question for an investor today is whether that growth is already more than accounted for in the fund’s price, which sits at a premium to its own recent past.

Paying More Than The Average
An index fund has no story, just a price and a basket of holdings. The simplest way to judge the price is against itself. Today, IJR trades at a trailing price-to-earnings (P/E) ratio of 20.6. For context, over the last five years, its average P/E has been 17.7. This means you are currently paying a price that is about 16% above that 5-year average. You are not getting a discount relative to the fund’s recent history; you are paying up.
- The Price of Reinvention for SanDisk Stock
- How Patience Re-Prices Marvell Technology Stock
- OXY Stock: When A Bargain Price Is A Message
- A 7-Day Winning Streak Has SailPoint Stock Up 20%
- MongoDB Stock Rides A 6-Day Winning Streak To A 20% Gain
- Procore Technologies Stock Rides A 7-Day Winning Streak To A 35% Gain
Is the Growth Story Worth the Premium?
The justification for paying a higher price often comes down to future growth. As mentioned, consensus estimates put one-year earnings growth for the fund’s holdings at about 15%. The fund’s forward P/E ratio is about 16.1, which looks more reasonable. However, it’s critical to know that these two P/E ratios are not comparable. The trailing 20.6 is a GAAP figure across all holdings, while the forward 16.1 is a non-GAAP figure that includes only profitable companies. The gap between them cannot be read as a market expectation of earnings growth. The real question is whether paying 16.1 times forward earnings is a sensible price for that 15% growth, especially when it comes from a diffuse basket of 674 positions. The five largest holdings make up just 2.6% of the fund, led by examples like Viasat (VSAT) at 0.6% and Corcept Therapeutics (CORT) at 0.5%.
A Thin Cushion for Taking Risk
Perhaps the sharpest way to frame the decision is to look at what the fund’s holdings are earning for you right now, compared to the safest alternative. The aggregate earnings yield of the stocks inside IJR is 4.9%. At the same time, a 10-year US Treasury yields 4.7%. That leaves you with a risk premium of just 0.2 percentage points for choosing the volatility of small-cap stocks over the certainty of a government bond. If earnings growth comes in weaker than expected, there is very little cushion in that yield to absorb the disappointment.
For an owner of IJR, the conclusion isn’t about buying or selling. It’s about understanding what you’re paying for. The price today is justified only if you believe the 15% earnings growth forecast will materialize, making the premium to the fund’s own history worthwhile. Buying an index means accepting the aggregate price for all 674 holdings. For investors who find that price too steep given the thin risk premium, the alternative is a more selective approach, seeking out individual companies rather than owning the entire basket. The number to watch is that growth forecast; it’s doing all the heavy lifting to justify today’s price.
Is There A Cheaper Way To Own The Same Exposure?
IJR sits close to its own historical price, which only sharpens the question of which funds are actually mispriced. ETFs are a smart way to own a theme or a market without picking single stocks, and the menu is enormous. That is the difficulty: funds offering nearly identical exposure can trade at very different valuations and carry very different risk, and most buyers never line them up side by side. Our ETF Valuation and Performance Scorecard does exactly that for the full equity universe, sorting by risk-adjusted return and flagging how each fund’s price compares with its own past. If you would rather not weigh it all yourself, the Trefis High Quality (HQ) Portfolio applies the same discipline a level deeper, with 30 individually screened names, rule-based re-balancing, and a record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.